Sanofi’s Dupixent scores big as the first FDA-approved treatment for eosinophilic esophagitis zbecker Fri, 05/20/2022 – 15:45 More: Sanofi's Dupixent scores big as the first FDA-approved treatment for eosinophilic esophagitis Source: fierce
read moreSanofi’s Xenpozyme, Lilly’s Olumiant among batch of new EU approvals kdunleavy Fri, 05/20/2022 – 10:54 More: Sanofi's Xenpozyme, Lilly's Olumiant among batch of new EU approvals Source: fierce
read moreGilead Sciences nabs top HIV philanthropic fundraising spot in the US, passing Gates Foundation zbecker Fri, 05/20/2022 – 10:06 More: Gilead Sciences nabs top HIV philanthropic fundraising spot in the US, passing Gates Foundation Source: fierce
read moreNovartis hands over Tasigna patent as part of coalition with Roche, BMS and more to boost cancer drug access in poor countries aliu Fri, 05/20/2022 – 09:40 More: Novartis hands over Tasigna patent as part of coalition with Roche, BMS
read moreFDA lays out framework for manufacturers and developers to tackle drug shortages fkansteiner Fri, 05/20/2022 – 09:13 More: FDA lays out framework for manufacturers and developers to tackle drug shortages Source: fierce
read moreThousands usually prescribed sleeping pills could be offered app-based treatment More: NICE recommends app-based treatment for insomnia over sleeping pills Source: News
read more© 1994 - 2022 B.M. Pharmaceuticals